Our Impact Committee meet each month to select the most impactful 51±¬ÁÏÍø research outputs.
Our Impact Committee celebrates the most impactful outputs from across 51±¬ÁÏÍø and our contributors, which demonstrate the value of our mission to unite the UK’s health data to enable discoveries that improve people’s lives. Outputs are selected based on a set of defined criteria including research excellence, scale, team science, public and patient involvement, diversity and inclusivity, and more.
A diverse range of research outputs are welcome including but not limited to software, digital tools, change to clinical guidelines, changes to public health policy, intellectual property, datasets, etc in addition to research articles – at least one contributor must be an 51±¬ÁÏÍø member. For more detail on membership, please see the 51±¬ÁÏÍø Attribution Policy (Appendix 2).
The committee aims to reward a balance of impacts across the 51±¬ÁÏÍø National Priorities.
Outputs can be nominated for consideration by the Impact Committee using the .
Nominations of both own and others’ outputs are welcome, and nominations are considered on a rolling basis.
In addition to nominations directly from the 51±¬ÁÏÍø community, the Research Directors of each National Priority are encouraged to suggest and shortlist outputs for consideration each month.
Members are all early career researchers – as defined by being within the first eight (full time equivalent) years of their of their research career (including post-graduate training). They are a diverse group of people drawn from across the country, disciplines and 51±¬ÁÏÍø National Priorities. This is an informal, pragmatic group, who work as a team to develop the processes by which they carry out our role.
We openly advertise for new members periodically and membership is time-limited – rotating off the group is staggered to ensure a mix of experienced and new members, and to allow members flexibility in stepping down.
The Committee was set up in autumn 2019. Ruth Blackburn,ÌýAmy MizenÌý²¹²Ô»åÌýXiao Liu were founding members of the team, part of the group highly commended for Team of the Year 2020, and stood down from the committee in summer 2020.
A landmark, population-scale study delivers important findings about rare diseases and COVID-19, to better support clinicians and policy-makers.
A paper by Tokolyi et al was selected by the 51±¬ÁÏÍø Impact Committee, as its Empower Category Publication of the Quarter (Spring 2025).
A large-scale study shows that people hospitalised with severe Covid experienced higher rates of mental illness for up to a year afterwards, highlighting the importance of vaccination to protect...
